OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is a publicly traded Healthcare sector company. As of July 28, 2026, OKUR trades at $4.05 with a market cap of $166.43M and a P/E ratio of -0.93. OKUR moved -1.70% today. Year to date, OKUR is +39.66%; over the trailing twelve months it is +75.32%. Its 52-week range spans $1.70 to $15.89. Analyst consensus is strong buy with an average price target of $22.33. Rallies surfaces OKUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks OKUR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $4.05 |
| Market Cap | $166.43M |
| P/E Ratio | -0.93 |
| EPS | $-4.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.89 |
| 52-Week Low | $1.70 |
| Volume | 71.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.43M |
| Net Income | $-59.52M |
| Gross Margin | 0.00% |
4 analysts cover OKUR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.33.